SUO 2022: Dr. Shore Presents Trial in Progress Phase I NMIBC Data

A Phase 1, Open-Label Trial to Determine Feasibility and Safety of Intramural Injection of Belzupacap Sarotalocan (AU-011) in Non-Muscle Invasive Bladder Cancer (NMIBC)